SGH
CLVS

Sivik Global Healthcare’s Clovis Oncology, Inc. CLVS Stock Holding History

Sivik Global Healthcare’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-55,000
Closed -$2.5M – 70
2018
Q2 		$2.5M Buy
+55,000
New +$2.67M 0.96% 44
2018
Q1 		– Sell
-35,000
Closed -$2.38M – 70
2017
Q4 		$2.38M Buy
35,000
+5,000
+17% +$350K 0.88% 52
2017
Q3 		$2.47M Buy
30,000
+10,000
+50% +$793K 0.84% 45
2017
Q2 		$1.87M Hold
20,000
– – 0.69% 51
2017
Q1 		$1.27M Buy
20,000
+5,000
+33% +$304K 0.59% 53
2016
Q4 		$666K Buy
+15,000
New +$528K 0.32% 54

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sivik Global Healthcare's CLVS Position: Q3 2018 in Review

Sivik Global Healthcare sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 55,000 shares — an estimated $2.5M sold.

Sivik Global Healthcare first reported a position in CLVS in Q4 2016 and held it in 6 quarters. The position peaked at $2.5M in Q2 2018. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • Sivik Global Healthcare reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • Sivik Global Healthcare sold 55,000 Clovis Oncology, Inc. shares in Q3 2018, an estimated $2.5M.
  • Sivik Global Healthcare first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 6 quarters.
  • Sivik Global Healthcare's Clovis Oncology, Inc. position peaked at $2.5M in Q2 2018.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on Sivik Global Healthcare's 13F filing for Q3 2018, filed 13 Nov 2018.